Imagine Health, Inc.

imaginehealth.com

Imagine Health is an exclusively high quality health plan and provider network delivering better care, a premium experience, and lower costs to its members and their employers. With a network shaped by the industry’s best data-driven methods for identifying the top tier of doctors, hospitals, and specialists, patients see the only the most effective providers. Personalized concierge assistance affords a low-stress experience for members that ensures their families get the right care and understand every step in straightforward terms.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

MEDICAL

ILC DOVER ANNOUNCES LIQUID SINGLE-USE BIOPROCESSING BAGS FOR RAPIDLY GROWING BIOTHERAPEUTICS AND CELL & GENE THERAPY MARKETS

ILC Dover | March 30, 2022

news image

ILC Dover LP ("ILC Dover" or the "Company"), specializing in innovative single-use solutions for biotherapeutics and pharmaceutical processing, announced its launch of liquid single-use bioprocessing bags, representing the first of many new products for handling and supply of sterile liquids for the biotherapeutics market. This expansion is a continuation of ILC Dover's solution set across the entire biotherapeutic and pharmaceutical manufacturing workflow, from powder co...

Read More

ILLUMINA INTRODUCES NEW PAN-CANCER COMPANION DIAGNOSTIC TO MATCH PATIENTS WITH RARE GENETIC MUTATIONS TO TARGETED THERAPY

Illumina | May 27, 2022

news image

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the addition of a companion diagnostic (CDx) indication to its CE-marked in vitro diagnostic TruSight™ Oncology (TSO) Comprehensive (EU) test. This single test kit, recently launched across Europe, assesses multiple tumor genes and biomarkers to reveal the specific molecular profile of a patient's cancer. The CDx pan-cancer indication will allow identification of cancer patien...

Read More

INDUSTRIAL IMPACT

CHARLES RIVER EXPANDS STRATEGIC PARTNERSHIP WITH SAMDI TECH

Charles River Laboratories International, Inc. | January 28, 2022

news image

Charles River Laboratories International, Inc. announced the expansion of their strategic partnership with Chicago, Illinois-based SAMDI Tech, Inc. Under the existing partnership, established in 2018, SAMDI Tech clients have access to Charles River’s collection of lead-like compounds for high-throughput screening. The expanded agreement establishes Charles River as the exclusive partner for the promotion of SAMDI Tech’s technology. This partnership will provide Charles River’s ...

Read More

AGC BIOLOGICS PARTNERS WITH TAKARA BIO TO MANUFACTURE PLASMID DNA VACCINE AGAINST COVID-19

AGC Biologics | May 22, 2020

news image

AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmaceuticals, has announced its partnership with Takara Bio. The companies will partner in the fight against COVID-19 by collaborating on a prophylaxis DNA vaccine,...

Read More
news image

MEDICAL

ILC DOVER ANNOUNCES LIQUID SINGLE-USE BIOPROCESSING BAGS FOR RAPIDLY GROWING BIOTHERAPEUTICS AND CELL & GENE THERAPY MARKETS

ILC Dover | March 30, 2022

ILC Dover LP ("ILC Dover" or the "Company"), specializing in innovative single-use solutions for biotherapeutics and pharmaceutical processing, announced its launch of liquid single-use bioprocessing bags, representing the first of many new products for handling and supply of sterile liquids for the biotherapeutics market. This expansion is a continuation of ILC Dover's solution set across the entire biotherapeutic and pharmaceutical manufacturing workflow, from powder co...

Read More
news image

ILLUMINA INTRODUCES NEW PAN-CANCER COMPANION DIAGNOSTIC TO MATCH PATIENTS WITH RARE GENETIC MUTATIONS TO TARGETED THERAPY

Illumina | May 27, 2022

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the addition of a companion diagnostic (CDx) indication to its CE-marked in vitro diagnostic TruSight™ Oncology (TSO) Comprehensive (EU) test. This single test kit, recently launched across Europe, assesses multiple tumor genes and biomarkers to reveal the specific molecular profile of a patient's cancer. The CDx pan-cancer indication will allow identification of cancer patien...

Read More
news image

INDUSTRIAL IMPACT

CHARLES RIVER EXPANDS STRATEGIC PARTNERSHIP WITH SAMDI TECH

Charles River Laboratories International, Inc. | January 28, 2022

Charles River Laboratories International, Inc. announced the expansion of their strategic partnership with Chicago, Illinois-based SAMDI Tech, Inc. Under the existing partnership, established in 2018, SAMDI Tech clients have access to Charles River’s collection of lead-like compounds for high-throughput screening. The expanded agreement establishes Charles River as the exclusive partner for the promotion of SAMDI Tech’s technology. This partnership will provide Charles River’s ...

Read More
news image

AGC BIOLOGICS PARTNERS WITH TAKARA BIO TO MANUFACTURE PLASMID DNA VACCINE AGAINST COVID-19

AGC Biologics | May 22, 2020

AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmaceuticals, has announced its partnership with Takara Bio. The companies will partner in the fight against COVID-19 by collaborating on a prophylaxis DNA vaccine,...

Read More